Drug
Argesun
Argesun: highest development phase Phase 2, developed by Shanghai Fosun Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shanghai Fosun Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Argesun 60mg (1 step parenteral artesunate) NCT05140278 | Phase 2 | Severe Malaria |
Latest
No recent events.
Follow Argesun on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.